{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:43:18Z","timestamp":1792633398826,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.resinv.2020.10.008","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T02:15:21Z","timestamp":1606875321000},"page":"53-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["What parameters can be used to identify early idiopathic pulmonary fibrosis?"],"prefix":"10.1016","volume":"59","author":[{"given":"Yuta","family":"Mori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Kondoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2020.10.008_bib1","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1164\/rccm.201006-0894CI","article-title":"Clinical course and prediction of survival in idiopathic pulmonary fibrosis","volume":"183","author":"Ley","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1513\/pats.200601-005TK","article-title":"Classification and natural history of the idiopathic interstitial pneumonias","volume":"3","author":"Kim","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.resinv.2020.10.008_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1183\/09031936.00106011","article-title":"Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study","volume":"40","author":"Mura","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2020.10.008_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1378\/chest.10-2572","article-title":"Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium","volume":"140","author":"Nathan","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2020.10.008_bib6","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.resinv.2020.10.008_bib7","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib8","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib9","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","article-title":"An official ATS\/ERS\/JRS\/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline","volume":"192","author":"Raghu","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib10","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1183\/13993003.01966-2015","article-title":"Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function","volume":"48","author":"Albera","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2020.10.008_bib11","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/thoraxjnl-2016-208710","article-title":"Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume","volume":"72","author":"Kolb","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2020.10.008_bib12","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1164\/rccm.201312-2219PP","article-title":"Genetics and early detection in idiopathic pulmonary fibrosis","volume":"189","author":"Putman","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib13","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib14","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1183\/09059180.00002114","article-title":"Staging of idiopathic pulmonary fibrosis: past, present and future","volume":"23","author":"Kolb","year":"2014","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.resinv.2020.10.008_bib15","doi-asserted-by":"crossref","first-page":"170047","DOI":"10.1183\/16000617.0047-2017","article-title":"Severe idiopathic pulmonary fibrosis: what can be done?","volume":"26","author":"Caminati","year":"2017","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.resinv.2020.10.008_bib16","doi-asserted-by":"crossref","first-page":"170051","DOI":"10.1183\/16000617.0051-2017","article-title":"Evaluating disease severity in idiopathic pulmonary fibrosis","volume":"26","author":"Robbie","year":"2017","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.resinv.2020.10.008_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.acra.2009.07.016","article-title":"Identification of early interstitial lung disease in smokers from the COPDGene Study","volume":"17","author":"Washko","year":"2010","journal-title":"Acad Radiol"},{"key":"10.1016\/j.resinv.2020.10.008_bib18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","article-title":"Progressive preclinical interstitial lung disease in rheumatoid arthritis","volume":"168","author":"Gochuico","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib19","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/rccm.201108-1420PP","article-title":"Identification of early interstitial lung disease in smokers from the COPDGene Study","volume":"185","author":"Doyle","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib20","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJMoa1007285","article-title":"Lung volumes and emphysema in smokers with interstitial lung abnormalities","volume":"364","author":"Washko","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12890-018-0575-y","article-title":"Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry","volume":"18","author":"Jo","year":"2018","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib22","first-page":"103","article-title":"Risk factors of acute exacerbation of idiopathic pulmonary fibrosis","volume":"27","author":"Kondoh","year":"2010","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.resinv.2020.10.008_bib23","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1183\/09031936.00159709","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome","volume":"37","author":"Song","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2020.10.008_bib24","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S2213-2600(19)30255-3","article-title":"Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study","volume":"7","author":"Maher","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib25","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/resp.12082","article-title":"Disease progression in idiopathic pulmonary fibrosis without pulmonary function impairment","volume":"18","author":"Kondoh","year":"2013","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2020.10.008_bib26","first-page":"257","article-title":"The presence of emphysema further impairs physiologic function in patients with idiopathic pulmonary fibrosis","volume":"51","author":"Mura","year":"2006","journal-title":"Respir Care"},{"key":"10.1016\/j.resinv.2020.10.008_bib27","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1164\/rccm.200412-1756OC","article-title":"High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis","volume":"172","author":"Lynch","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib28","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1148\/radiol.2463062200","article-title":"Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality","volume":"246","author":"Best","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.resinv.2020.10.008_bib29","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1164\/rccm.200611-1696OC","article-title":"Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival","volume":"177","author":"Sumikawa","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib30","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s11547-015-0526-0","article-title":"Idiopathic interstitial pneumonias: do HRCT criteria established by ATS\/ERS\/JRS\/ALAT in 2011 predict disease progression and prognosis?","volume":"120","author":"Romei","year":"2015","journal-title":"Radiol Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1148\/radiol.14130216","article-title":"Idiopathic pulmonary fibrosis: CT and risk of death","volume":"273","author":"Ley","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.resinv.2020.10.008_bib32","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1164\/rccm.201607-1385OC","article-title":"Idiopathic pulmonary fibrosis: the association between the adaptive multiple features method and fibrosis outcomes","volume":"195","author":"Salisbury","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166168","article-title":"Clinical course and changes in high-resolution computed tomography findings in patients with idiopathic pulmonary fibrosis without honeycombing","volume":"11","author":"Yamauchi","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2020.10.008_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.rmed.2018.07.014","article-title":"Evolution of diagnostic UIP computed tomography patterns in idiopathic pulmonary fibrosis: disease spectrum and implications for survival","volume":"142","author":"De Giacomi","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/thorax.58.2.143","article-title":"Radiological versus histological diagnosis in UIP and NSIP: survival implications","volume":"58","author":"Flaherty","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2020.10.008_bib36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/thx.2010.140574","article-title":"Long-term follow-up high-resolution CT findings in non-specific interstitial pneumonia","volume":"66","author":"Akira","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2020.10.008_bib37","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1007\/s00330-011-2098-2","article-title":"Fibrotic idiopathic interstitial pneumonias: HRCT findings that predict mortality","volume":"21","author":"Edey","year":"2011","journal-title":"Eur Radiol"},{"key":"10.1016\/j.resinv.2020.10.008_bib38","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1007\/s00330-012-2427-0","article-title":"Chronic hypersensitivity pneumonitis: high resolution computed tomography patterns and pulmonary function indices as prognostic determinants","volume":"22","author":"Walsh","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.resinv.2020.10.008_bib39","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00092309","article-title":"Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease","volume":"35","author":"Kim","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2020.10.008_bib40","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1378\/chest.09-0108","article-title":"Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study","volume":"136","author":"Goldin","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2020.10.008_bib41","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/thoraxjnl-2013-203843","article-title":"Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants","volume":"69","author":"Walsh","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2020.10.008_bib42","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1513\/AnnalsATS.201807-443OC","article-title":"Computed tomography honeycombing identifies a progressive fibrotic phenotype with increased mortality across diverse interstitial lung diseases","volume":"16","author":"Adegunsoye","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.resinv.2020.10.008_bib43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.rmed.2017.08.025","article-title":"Possible UIP pattern on high-resolution computed tomography is associated with better survival than definite UIP in IPF patients","volume":"131","author":"Salisbury","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib44","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.rmed.2015.02.008","article-title":"Clinical findings and outcomes in patients with possible usual interstitial pneumonia","volume":"109","author":"Lee","year":"2015","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1164\/rccm.201602-0402OC","article-title":"Effect of nintedanib in subgroups of idiopathic pulmonary fibrosis by diagnostic criteria","volume":"195","author":"Raghu","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib46","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1148\/radiol.12112516","article-title":"Interobserver variability in the CT assessment of honeycombing in the lungs","volume":"266","author":"Watadani","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.resinv.2020.10.008_bib47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1148\/radiol.2282020274","article-title":"Quantitative CT indexes in idiopathic pulmonary fibrosis: relationship with physiologic impairment","volume":"228","author":"Best","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.resinv.2020.10.008_bib48","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1164\/ajrccm.159.2.9707145","article-title":"Interstitial lung disease: a quantitative study using the adaptive multiple feature method","volume":"159","author":"Uppaluri","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib49","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12916-016-0739-7","article-title":"Evaluation of computer-based computer tomography stratification against outcome models in connective tissue disease-related interstitial lung disease: a patient outcome study","volume":"14","author":"Jacob","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib50","doi-asserted-by":"crossref","first-page":"1601011","DOI":"10.1183\/13993003.01011-2016","article-title":"Mortality prediction in idiopathic pulmonary fibrosis: evaluation of computer-based CT analysis with conventional severity measures","volume":"49","author":"Jacob","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2020.10.008_bib51","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1183\/09031936.00071812","article-title":"Automated quantification of radiological patterns predicts survival in idiopathic pulmonary fibrosis","volume":"43","author":"Maldonado","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2020.10.008_bib52","doi-asserted-by":"crossref","first-page":"108852","DOI":"10.1016\/j.ejrad.2020.108852","article-title":"Automated computed tomography analysis in the assessment of idiopathic pulmonary fibrosis severity and progression","volume":"124","author":"Romei","year":"2020","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.resinv.2020.10.008_bib53","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1148\/radiol.2017161177","article-title":"Idiopathic pulmonary fibrosis: data-driven textural analysis of extent of fibrosis at baseline and 15-month follow-up","volume":"285","author":"Humphries","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.resinv.2020.10.008_bib54","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejrad.2017.02.037","article-title":"The importance of subpleural fibrosis in the prognosis of patients with idiopathic interstitial pneumonias","volume":"90","author":"Iwasawa","year":"2017","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.resinv.2020.10.008_bib55","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1148\/radiol.2019182466","article-title":"Computer-aided quantification of pulmonary fibrosis in patients with lung cancer: relationship to disease-free survival","volume":"292","author":"Iwasawa","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.resinv.2020.10.008_bib56","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1148\/radiol.2018172688","article-title":"Idiopathic pulmonary fibrosis: data-driven textural analysis of extent of fibrosis at baseline and 15-month follow-up","volume":"288","author":"Ash","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.resinv.2020.10.008_bib57","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/resp.12989","article-title":"Health-related quality of life in idiopathic pulmonary fibrosis: data from the Australian IPF Registry","volume":"22","author":"Glaspole","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2020.10.008_bib58","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00084-2017","article-title":"mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis","volume":"3","author":"Rajala","year":"2017","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.resinv.2020.10.008_bib59","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12931-019-1020-3","article-title":"The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF Registry","volume":"20","author":"Kreuter","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2020.10.008_bib60","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.resinv.2014.11.001","article-title":"A prospective survey of idiopathic interstitial pneumonias in a web registry in Japan","volume":"53","author":"Bando","year":"2015","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2020.10.008_bib61","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.rmed.2004.10.018","article-title":"The Medical Research Council dyspnea scale in the estimation of disease severity in idiopathic pulmonary fibrosis","volume":"99","author":"Papiris","year":"2005","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib62","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1183\/09031936.00152609","article-title":"A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis","volume":"36","author":"Nishiyama","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2020.10.008_bib63","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1164\/rccm.201011-1790OC","article-title":"Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis","volume":"184","author":"Du Bois","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib64","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/resp.12945","article-title":"A simple dyspnoea scale as part of the assessment to predict outcome across chronic interstitial lung disease","volume":"22","author":"Khadawardi","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2020.10.008_bib65","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1440-1843.2011.01996.x","article-title":"Cough predicts prognosis in idiopathic pulmonary fibrosis","volume":"16","author":"Ryerson","year":"2011","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2020.10.008_bib66","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12955-014-0124-1","article-title":"The psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review","volume":"12","author":"Swigris","year":"2014","journal-title":"Health Qual Life Outcome"},{"key":"10.1016\/j.resinv.2020.10.008_bib67","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/thoraxjnl-2012-201581","article-title":"The development and validation of the King\u2019s Brief Interstitial Lung Disease (K-BILD) health status questionnaire","volume":"67","author":"Patel","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2020.10.008_bib68","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12931-017-0503-3","article-title":"The St. George\u2019s Respiratory Questionnaire as a prognostic factor in IPF","volume":"18","author":"Furukawa","year":"2017","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2020.10.008_bib69","first-page":"113","article-title":"Health-related quality of life does not predict mortality in idiopathic pulmonary fibrosis","volume":"29","author":"Nishiyama","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.resinv.2020.10.008_bib70","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1159\/000089656","article-title":"Functional predictors of exertional dyspnea, 6-min walking distance and HRCT fibrosis score in idiopathic pulmonary fibrosis","volume":"73","author":"Mura","year":"2006","journal-title":"Respiration"},{"key":"10.1016\/j.resinv.2020.10.008_bib71","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/thx.2010.139121","article-title":"Development and validity testing of an IPF-specific version of the St George's respiratory questionnaire","volume":"65","author":"Yorke","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2020.10.008_bib72","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.2169\/internalmedicine.56.7019","article-title":"Depression is significantly associated with the health status in patients with idiopathic pulmonary fibrosis","volume":"56","author":"Matsuda","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib73","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1164\/rccm.2111053","article-title":"Idiopathic pulmonary fibrosis: a composite physiological index derived from disease extent observed by computed tomography","volume":"167","author":"Wells","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib74","doi-asserted-by":"crossref","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","article-title":"A multidimensional index and staging system for idiopathic pulmonary fibrosis","volume":"156","author":"Ley","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib75","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1378\/chest.15-0530","article-title":"Idiopathic pulmonary fibrosis: gender\u2013age\u2013physiology index stage for predicting future lung function decline","volume":"149","author":"Salisbury","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2020.10.008_bib76","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00127-2018","article-title":"Effects of nintedanib in patients with idiopathic pulmonary fibrosis by GAP stage","volume":"5","author":"Ryerson","year":"2019","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.resinv.2020.10.008_bib77","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.resinv.2016.02.009","article-title":"Validation of the Japanese disease severity classification and the GAP model in Japanese patients with idiopathic pulmonary fibrosis","volume":"54","author":"Kondoh","year":"2016","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2020.10.008_bib78","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1378\/chest.14-0453","article-title":"Validation of the GAP score in Korean patients with idiopathic pulmonary fibrosis","volume":"147","author":"Kim","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2020.10.008_bib79","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.resinv.2014.08.003","article-title":"Usefulness of a disease severity staging classification system for IPF in Japan: 20 years of experience from empirical evidence to randomized control trial enrollment","volume":"53","author":"Homma","year":"2015","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2020.10.008_bib80","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/resp.13138","article-title":"Disease severity staging system for idiopathic pulmonary fibrosis in Japan","volume":"22","author":"Kondoh","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2020.10.008_bib81","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.resinv.2015.06.001","article-title":"All-case post-marketing surveillance of 1371 patients treated with pirfenidone for idiopathic pulmonary fibrosis","volume":"53","author":"Ogura","year":"2015","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2020.10.008_bib82","first-page":"181684","article-title":"Interstitial lung abnormality: recognition and perspectives","author":"Hatabu","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.resinv.2020.10.008_bib83","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1056\/NEJMoa1216076","article-title":"MUC5B promoter polymorphism and interstitial lung abnormalities","volume":"368","author":"Hunninghake","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib84","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1164\/rccm.201109-1618OC","article-title":"Interstitial lung abnormalities and reduced exercise capacity","volume":"185","author":"Doyle","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib85","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.13120816","article-title":"Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate","volume":"268","author":"Jin","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.resinv.2020.10.008_bib86","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jama.2016.0518","article-title":"Association between interstitial lung abnormalities and all-cause mortality","volume":"315","author":"Putman","year":"2016","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.resinv.2020.10.008_bib87","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.rmed.2018.02.001","article-title":"Interstitial lung abnormalities are associated with increased mortality in smokers","volume":"136","author":"Hoyer","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib88","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1164\/rccm.201612-2431OC","article-title":"Occupational exposures and subclinical interstitial lung disease. The MESA (Multi-Ethnic Study of Atherosclerosis) air and lung studies","volume":"196","author":"Sack","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib89","doi-asserted-by":"crossref","first-page":"1700559","DOI":"10.1183\/13993003.00559-2017","article-title":"Air pollution and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA) air-lung study","volume":"50","author":"Sack","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2020.10.008_bib90","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1164\/rccm.201903-0511OC","article-title":"Overlap of genetic risk between interstitial lung abnormalities and idiopathic pulmonary fibrosis","volume":"200","author":"Hobbs","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib91","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1164\/rccm.201512-2523OC","article-title":"Development and progression of interstitial lung abnormalities in the Framingham Heart Study","volume":"194","author":"Araki","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib92","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1164\/rccm.201809-1652OC","article-title":"Imaging patterns are associated with interstitial lung abnormality progression and mortality","volume":"200","author":"Putman","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib93","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1164\/rccm.201708-1679LE","article-title":"Histopathology of interstitial lung abnormalities in the context of lung nodule resections","volume":"197","author":"Miller","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib94","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1164\/rccm.201604-0818LE","article-title":"Interstitial lung abnormalities are associated with acute respiratory distress syndrome","volume":"195","author":"Putman","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib95","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1164\/rccm.201607-1363ED","article-title":"Subclinical interstitial lung abnormalities: toward the early detection of idiopathic pulmonary fibrosis?","volume":"194","author":"Wells","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2020.10.008_bib96","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.resinv.2018.06.001","article-title":"Significance of molecular biomarkers in idiopathic pulmonary fibrosis: a mini review","volume":"56","author":"Chiba","year":"2018","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2020.10.008_bib97","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S2213-2600(18)30286-8","article-title":"Deep learning for classifying fibrotic lung disease on high-resolution computed tomography: a case-cohort study","volume":"6","author":"Walsh","year":"2018","journal-title":"Lancet Respir Med"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534520301593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534520301593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:31:03Z","timestamp":1761949863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534520301593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S2212534520301593"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2020.10.008","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What parameters can be used to identify early idiopathic pulmonary fibrosis?","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2020.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}